Medidata Launches Programs to Address Two Critical Social Needs: Advancing Patient Access to Treatments and Increasing Student Participation in STEM Education

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Medidata, the global leader in creating end-to-end solutions supporting the entire clinical trial process, and a Dassault Syst¨mes company, announced three new social impact initiatives within its expanding corporate social responsibility (CSR) program: Social Innovation Lab, Founders Scholarship, and MediEd. These programs are designed to make a difference in the lives of patients and researchers and are part of Medidatas mission to power smarter treatments and healthier people.

Social Innovation Lab: Medidata employee volunteers participate in cross-functional teams to support non-profit partners with programs that expand patient access to treatment. These efforts include:

  • The Castleman Disease Collaborative Network and the Castleman Disease Center for Excellence at the University of Pennsylvania – working to optimize organizational synergies, digital communications, and data utilization to accelerate the discovery of treatments
  • Cures Within Reach – creating a more user-friendly experience on their CureAcceleratorTM platform, which connects researchers, funders, and industry and patient groups, to help expand the number of users and reach into the developing world
  • The Lazarex Cancer Foundation – creating a data-driven analysis of key cancer centers across the United States to support the expanded Foundation IMPACT program, which helps increase patient diversity in clinical trials and provides assistance for out-of-pocket costs

The collaboration with Medidata is a game changer for us, vastly expanding the limited resources of Lazarex to complete research projects that are well beyond the scope of what we can accomplish on our own, said Dana Dornsife, founder and board chair, Lazarex. The Medidata results are vital for us to make evidence-based decisions, elevating us from trial and error efforts to taking strategic and precise program actions.

Founders Scholarship: In honor of Medidatas 20th Anniversary, the Founders Scholarship program will provide a $20,000 scholarship in support of a junior or senior college student pursuing a STEM education. The recipient will also receive an internship at Medidatas headquarters in New York City during the summer of 2020. Scholarship criteria include grade point average, financial need, extracurricular activities and community involvement.

MediEd: MediEd helps students prepare for careers in the life sciences industry by providing them with practical experience in key competencies for data management and informatics, study and site management, and ethical considerations for clinical trials. Medidata is donating its Rave EDC (electronic data capture) software to selected universities to capture, cleanse, and manage study data across every phase of the clinical trial life cycle. The partnership started with the University of North Carolina at Wilmington, and has now expanded to include Durham Technical Community College and Campbell University.

At Medidata, we are committed to leveraging our expertise in life sciences and technology to have a positive impact on patients and students, said Tarek Sherif, co-CEO and co-founder, Medidata. These three programs exemplify our commitment to powering a future where everyone has access to treatment and education.

About Medidata

Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,400 customers and partners access the world’s most-used platform for clinical development, commercial, and real-world data. Medidata, a Dassault Syst¨mes company (Euronext Paris: #13065, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata, The Operating System for Life SciencesTM.

Medidata and Medidata Rave are registered trademarks of Medidata Solutions, Inc., a wholly owned subsidiary of Dassault Syst¨mes.

Media:

Rosemarie Esposito

646-362-3017

[email protected]